292 related articles for article (PubMed ID: 33025632)
1. The roles of small-molecule inflammatory mediators in rheumatoid arthritis.
Cheng Q; Wu H; Du Y
Scand J Immunol; 2021 Mar; 93(3):e12982. PubMed ID: 33025632
[TBL] [Abstract][Full Text] [Related]
2. Selected cytokine pathways in rheumatoid arthritis.
Noack M; Miossec P
Semin Immunopathol; 2017 Jun; 39(4):365-383. PubMed ID: 28213794
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
Meroni PL; Valesini G
BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
[TBL] [Abstract][Full Text] [Related]
4. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
5. TNF as a Target of Inflammation in Rheumatoid Arthritis.
Yamanaka H
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):129-34. PubMed ID: 25772178
[TBL] [Abstract][Full Text] [Related]
6. Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis.
Park YH; Kim HJ; Lee K; Choi Y; Heo TH
Biochem Biophys Res Commun; 2020 Feb; 522(4):1030-1036. PubMed ID: 31818460
[TBL] [Abstract][Full Text] [Related]
7. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
Azizi G; Jadidi-Niaragh F; Mirshafiey A
Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4.
Ichise Y; Saegusa J; Tanaka-Natsui S; Naka I; Hayashi S; Kuroda R; Morinobu A
Cells; 2020 Jul; 9(7):. PubMed ID: 32674360
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis.
Chen DP; Wong CK; Leung PC; Fung KP; Lau CB; Lau CP; Li EK; Tam LS; Lam CW
J Ethnopharmacol; 2011 Sep; 137(1):457-68. PubMed ID: 21679760
[TBL] [Abstract][Full Text] [Related]
10. Biological response modifiers in the management of rheumatoid arthritis.
Louie SG; Park B; Yoon H
Am J Health Syst Pharm; 2003 Feb; 60(4):346-55. PubMed ID: 12625216
[TBL] [Abstract][Full Text] [Related]
11. [Rheumatoid arthritis and cytokines].
Kaneko S; Kondo Y; Yokosawa M; Sumida T
Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
[TBL] [Abstract][Full Text] [Related]
12. Gastrodia elata attenuates inflammatory response by inhibiting the NF-κB pathway in rheumatoid arthritis fibroblast-like synoviocytes.
Li Y; Wang LM; Xu JZ; Tian K; Gu CX; Li ZF
Biomed Pharmacother; 2017 Jan; 85():177-181. PubMed ID: 27936399
[TBL] [Abstract][Full Text] [Related]
13. Lipid mediators of inflammation in rheumatoid arthritis and osteoarthritis.
Brouwers H; von Hegedus J; Toes R; Kloppenburg M; Ioan-Facsinay A
Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):741-55. PubMed ID: 27107510
[TBL] [Abstract][Full Text] [Related]
14. IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions.
Woodrick RS; Ruderman EM
Bull NYU Hosp Jt Dis; 2012; 70(3):195-9. PubMed ID: 23259628
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
[TBL] [Abstract][Full Text] [Related]
16. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor.
Christie PE; Henderson WR
Clin Allergy Immunol; 2002; 16():233-54. PubMed ID: 11577541
[TBL] [Abstract][Full Text] [Related]
17. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 in rheumatoid arthritis - from the laboratory to the bedside.
Liu X; Teichtahl AJ; Wicks IP
Curr Pharm Des; 2015; 21(17):2187-97. PubMed ID: 25760299
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of anti-cytokines and anti-RANKL antibody for treatment of RA and osteoporosis].
Okada Y; Nawata M; Tanaka Y
Clin Calcium; 2007 Nov; 17(11):1762-8. PubMed ID: 17982198
[TBL] [Abstract][Full Text] [Related]
20. [Interleukins network in rheumatoid arthritis pathophysiology: beyond proinflammatory cytokines].
Sánchez-Ramón S; López-Longo FJ; Carreño L
Reumatol Clin; 2011 Mar; 6S3():S20-4. PubMed ID: 21794767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
